You appear to be using incognito/private browsing mode or an ad blocker, which may adversely affect your experience on the site. Please disable any ad blockers and view the site in non-private mode.
For in vitro diagnostic use. Others Elecsys IGFBP-3 IVD Elecsys® IGFBP-3 CPS_000489 07574690190 IGFBP-3 Elecsys cobas e 100 Elecsys IGFBP-3 07613336142677 Reagents, kits 100 tests cobas e 411/601/602 true 07574720190 IGFBP-3 Elecsys E2G 100 Elecsys IGFBP-3 07613336142684 Reagents, kits 100 tests cobas e 402/801 true 07574690500 Elecsys IGFBP-3 en 3 FF000000067B150E FF000000030F0F0E 07574690190 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of insulin‑like growth factor binding protein‑3 (IGFBP‑3) in human serum and plasma. The IGFBP‑3 determination is intended to be used as an aid in the assessment of growth disorders in conjunction with other clinical and laboratory findings.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 07574690501 Elecsys IGFBP-3 en 2 FF000000065EF50E FF000000030D7D0E 07574690190 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of insulin‑like growth factor binding protein‑3 (IGFBP‑3) in human serum and plasma. The IGFBP‑3 determination is intended to be used as an aid in the assessment of growth disorders in conjunction with other clinical and laboratory findings.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 07574720501 Elecsys IGFBP-3 en 3 FF000000065EF70E FF000000030D810E 07574720190 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of insulin‑like growth factor binding protein‑3 (IGFBP‑3) in human serum and plasma. The IGFBP‑3 determination is intended to be used as an aid in the assessment of growth disorders in conjunction with other clinical and laboratory findings.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 07574720500 Elecsys IGFBP-3 en 1 FF000000030EEA0E FF000000030EEA0E 07574720190 2497 cobas e 801 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of insulin‑like growth factor binding protein‑3 (IGFBP‑3) in human serum and plasma. The IGFBP‑3 determination is intended to be used as an aid in the assessment of growth disorders in conjunction with other clinical and laboratory findings.The electrochemiluminescence immunoassay “ECLIA” is intended for use on the cobas e 801 immunoassay analyzer. en 07574720500 Elecsys IGFBP-3 en 5 FF000000067B120E FF00000004959A0E 07574720190 2497 cobas e 801 9494 cobas e 402 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of insulin‑like growth factor binding protein‑3 (IGFBP‑3) in human serum and plasma. The IGFBP‑3 determination is intended to be used as an aid in the assessment of growth disorders in conjunction with other clinical and laboratory findings.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en